We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
-7.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
-$54.2M
(-34%)
Cap. Flow
-$24M
Cap. Flow
% of AUM
-22.49%
Top 10 Holdings %
Top 10 Hldgs %
54.93%
Holding
347
New
45
Increased
19
Reduced
60
Closed
132
Avg Time Held Equity + Options
4.4
quarters
Top 10 Avg Time Held Equity + Options
2.2
quarters
Top 20 Avg Time Held Equity + Options
2.4
quarters
Avg Time Held Equity only
4.6
quarters
Top 10 Avg Time Held Equity only
3.6
quarters
Top 20 Avg Time Held Equity only
3.2
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.59M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.36M |
| 3 |
Silicon Motion
SIMO
|
+$870K |
| 4 |
Amazon
AMZN
|
+$758K |
| 5 |
LNKD
LinkedIn Corporation
LNKD
|
+$596K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
bluebird bio
BLUE
|
+$1.75M |
| 2 |
CSOD
Cornerstone OnDemand, Inc.
CSOD
|
+$957K |
| 3 |
Capri Holdings
CPRI
|
+$842K |
| 4 |
Sage Therapeutics
SAGE
|
+$803K |
| 5 |
CY
Cypress Semiconductor
CY
|
+$764K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 45.84% |
| 2 | Miscellaneous | 25.05% |
| 3 | Healthcare | 9.93% |
| 4 | Consumer Discretionary | 6.85% |
| 5 | Technology | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
FRGI
51
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $363K | 0.34% |
8,000
-2,000
| -20% | -$103K |
2013 Q2
9 quarters
|
|
|
BVA
52
DELISTED
CORDIA BANCORP INC COM
BVA
| $359K | 0.34% |
99,900
-200
| -0.2% | -$765 |
2014 Q3
4 quarters
|
|
|
SGEN
53
DELISTED
Seagen Inc. Common Stock
SGEN
| $332K | 0.31% |
8,600
-3,000
| -26% | -$135K |
2013 Q2
9 quarters
|
|
|
BNCL
54
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $332K | 0.31% |
25,000
| – | – |
2015 Q1
2 quarters
|
|
55
CALL
Ulta Beauty
ULTA
$24.3B
| $327K | 0.31% |
+2,000
| New | +$329K |
2015 Q3
0 quarters
|
|
56
DELISTED
Mr. Cooper
COOP
| $325K | 0.3% |
+10,417
| New | +$331K |
2015 Q3
0 quarters
|
|
|
FRE.PRZ
57
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
| $319K | 0.3% |
65,000
-5,000
| -7% | -$24.5K |
2013 Q2
9 quarters
|
|
58
Blackstone
BX
$86.2B
| $317K | 0.3% |
10,190
-5,095
| -33% | -$184K |
2013 Q2
9 quarters
|
|
59
Ethan Allen Interiors
ETD
$512M
| $304K | 0.29% |
11,500
+1,500
| +15% | +$44K |
2015 Q1
2 quarters
|
|
60
ScottsMiracle-Gro
SMG
$2.91B
| $304K | 0.29% |
+5,000
| New | +$309K |
2015 Q3
0 quarters
|
|
61
DBV Technologies S.A. American Depositary Shares
DBVT
$600M
| $303K | 0.28% |
+851
| New | +$335K |
2015 Q3
0 quarters
|
|
|
PFPT
62
DELISTED
Proofpoint, Inc.
PFPT
| $302K | 0.28% |
5,000
| – | – |
2015 Q2
1 quarter
|
|
|
FCE.A
63
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $302K | 0.28% |
+15,000
| New | +$331K |
2015 Q3
0 quarters
|
|
64
Penumbra
PEN
$12.6B
| $301K | 0.28% |
+7,500
| New | +$303K |
2015 Q3
0 quarters
|
|
65
Zoetis
ZTS
$31.3B
| $288K | 0.27% |
7,000
-5,000
| -42% | -$232K |
2013 Q4
7 quarters
|
|
|
AERI
66
DELISTED
Aerie Pharmaceuticals
AERI
| $284K | 0.27% |
16,000
| – | – |
2015 Q2
1 quarter
|
|
|
LUB
67
DELISTED
Luby's Inc.
LUB
| $284K | 0.27% |
57,058
-37,942
| -40% | -$187K |
2013 Q2
9 quarters
|
|
|
FNM
68
DELISTED
FANNIE MAE
FNM
| $281K | 0.26% |
125,000
| – | – |
2014 Q4
3 quarters
|
|
69
RH
RH
$2.21B
| $280K | 0.26% |
3,000
-1,000
| -25% | -$98.5K |
2013 Q2
9 quarters
|
|
|
DMND
70
DELISTED
DIAMOND FOODS, INC.
DMND
| $278K | 0.26% |
9,000
-1,000
| -10% | -$31.3K |
2015 Q2
1 quarter
|
|
71
Beacon Financial Corp
BBT
$2.29B
| $275K | 0.26% |
10,000
| – | – |
2013 Q2
9 quarters
|
|
72
DELISTED
General Motors Company
GM.WS.B
| $266K | 0.25% |
20,107
-10,000
| -33% | -$136K |
2013 Q2
9 quarters
|
|
73
Plains GP Holdings
PAGP
$5.29B
| $263K | 0.25% |
5,633
-1,877
| -25% | -$105K |
2014 Q4
3 quarters
|
|
|
ISEE
74
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $263K | 0.25% |
+6,500
| New | +$344K |
2015 Q3
0 quarters
|
|
75
Arrowhead Research
ARWR
$8.58B
| $259K | 0.24% |
45,000
-10,000
| -18% | -$62.9K |
2014 Q4
3 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q3 2015 Portfolio in Review
As of Q3 2015, E.E. Geduld held 347 positions worth $107M, down 34% from $161M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
E.E. Geduld withdrew a net $24M in Q3 2015, closing 132 positions and reducing 60 holdings. Its most notable exit was bluebird bio, an estimated $1.75M position sold in full.
By sector, the portfolio is most concentrated in Financials at 46% of assets, up from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Bristol-Myers Squibb worth $1.48M.
- E.E. Geduld's largest Q3 2015 buy was Bristol-Myers Squibb: 25,000 shares worth $1.48M.
- E.E. Geduld added most to Amazon in Q3 2015, an estimated $758K increase.
- E.E. Geduld's biggest Q3 2015 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $578K.
- E.E. Geduld fully exited bluebird bio in Q3 2015, selling an estimated $1.75M.
- E.E. Geduld's ten largest holdings make up 55% of its $107M portfolio in Q3 2015.
- E.E. Geduld opened 45 new positions and closed 132 in Q3 2015.
- E.E. Geduld's portfolio value fell 34% quarter-over-quarter to $107M.
Based on E.E. Geduld's 13F filing for Q3 2015, filed 6 Nov 2015.